Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-4-13
pubmed:abstractText
Large clinical studies assessing long-term adefovir dipivoxil salvage monotherapy in patients with lamivudine-resistant chronic hepatitis B (CHB) are lacking, particularly in patients positive for hepatitis B e antigen (HBeAg). We assessed the efficacy and resistance profile of adefovir dipivoxil monotherapy for up to 5 years in a large cohort of Korean patients with lamivudine-resistant CHB.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
2040-2058
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
235-41
pubmed:meshHeading
pubmed-meshheading:20386079-Adenine, pubmed-meshheading:20386079-Adult, pubmed-meshheading:20386079-Aged, pubmed-meshheading:20386079-Antiviral Agents, pubmed-meshheading:20386079-DNA, Viral, pubmed-meshheading:20386079-Drug Resistance, Viral, pubmed-meshheading:20386079-Female, pubmed-meshheading:20386079-Hepatitis B, Chronic, pubmed-meshheading:20386079-Hepatitis B e Antigens, pubmed-meshheading:20386079-Hepatitis B virus, pubmed-meshheading:20386079-Humans, pubmed-meshheading:20386079-Korea, pubmed-meshheading:20386079-Lamivudine, pubmed-meshheading:20386079-Male, pubmed-meshheading:20386079-Middle Aged, pubmed-meshheading:20386079-Phosphonic Acids, pubmed-meshheading:20386079-Reverse Transcriptase Inhibitors, pubmed-meshheading:20386079-Time Factors, pubmed-meshheading:20386079-Treatment Outcome, pubmed-meshheading:20386079-Young Adult
pubmed:year
2010
pubmed:articleTitle
Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.
pubmed:affiliation
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't